IBT
MRNS

International Biotechnology Trust’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

International Biotechnology Trust’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$2.34M Buy
290,000
+200,000
+222% +$1.66M 0.79% 36
2023
Q2 		$977K Buy
+90,000
New +$771K 0.3% 47

Other funds holding MRNS

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

International Biotechnology Trust's MRNS Position: Q3 2023 in Review

International Biotechnology Trust increased its Marinus Pharmaceuticals, Inc (MRNS) stake by 222% in Q3 2023, buying an estimated $1.66M and bringing the position to 290,000 shares worth $2.34M. The position accounts for 0.79% of the portfolio, ranked #36.

International Biotechnology Trust first reported a position in MRNS in Q2 2023 and has held it in 2 quarters since. 104 funds tracked by Wall St. Rank hold MRNS as of Q3 2023.

  • International Biotechnology Trust held 290,000 shares of Marinus Pharmaceuticals, Inc worth $2.34M as of Q3 2023.
  • International Biotechnology Trust bought 200,000 Marinus Pharmaceuticals, Inc shares in Q3 2023, an estimated $1.66M.
  • Marinus Pharmaceuticals, Inc made up 0.79% of International Biotechnology Trust's portfolio in Q3 2023, its #36 holding.
  • International Biotechnology Trust first reported a position in Marinus Pharmaceuticals, Inc in Q2 2023 and has held it in 2 quarters since.
  • 104 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q3 2023.

Based on International Biotechnology Trust's 13F filing for Q3 2023, filed 14 Nov 2023.